scholarly journals Characterization of Oral bacteriome dysbiosis in type 2 diabetic patients

2020 ◽  
Author(s):  
Junaid Ahmed Kori ◽  
Faizan Saleem ◽  
Saeed Ullah ◽  
M. Kamran Azim
Keyword(s):  
Oral Microbiome ◽  
P Value ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Dental Biofilm ◽  
The Usa ◽  
Similar Report ◽  
Fermentable Carbohydrates ◽  
Stratified Analysis ◽  
Relationship Of

AbstractWe aimed to characterize the relationship of the oral microbiome with diabetes in Pakistan. Saliva samples were collected from diabetic patients (n = 49) and healthy individuals (n = 55). 16S metagenomics saliva was carried out by NGS technology. We observed that the phylum Firmicutes (p-value = 0.024 at 95% confidence interval) was significantly more abundant among diabetic patients than among the controls. We found that the abundance of phylum Actinobacteria did not significantly vary among both groups in contrast to a similar report from the USA (Long et al., 2017). On genus level, acidogenic bacteria Prevotella (p-value = 0.024) and Leptotrichia (p-value = 1.5 × 10−3); and aciduric bacteria Veillonella (p-value = 0.013) were found to be in higher abundance in diabetic patients. These bacteria are found in dental biofilm and involved in the metabolism of fermentable carbohydrates. Stratified analysis by gender revealed healthy and diabetic females to be more divergent. Abundance of Prevotella (p-value = 4.4 × 10-3) and Leptotrichia (p-value = 0.015) was significantly associated with male patients. A comparison of oral bacteriome between two groups revealed the dominance of acidogenic and aciduric bacteria in diabetics which suggested the involvement of these eubacteria in oral dysbacteriosis in diabetes mellitus.

scholarly journals The Relationship of Diastolic Dysfunction And Microalbuminuria in Type 2 Diabetic Patients

1999 ◽  
Vol 9 (2) ◽  
pp. 92-97
Author(s):  
Didem Dereli ◽  
Harun Yenice ◽  
Murat Akyurt ◽  
Ebru Yüksel Özbal ◽  
Ziya Günal
Keyword(s):  
Diastolic Dysfunction ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Relationship Of ◽  
The Relationship ◽  
Type 2 Diabetic

scholarly journals Stringent glycemic control is still the key to evade diabetic retinopathy.

2020 ◽  
Vol 27 (05) ◽  
pp. 1011-1016
Author(s):  
Syed Munawar Alam ◽  
Sagheer Ahmed ◽  
Shazia Bano ◽  
Shahneela Perveen
Keyword(s):  
Diabetic Retinopathy ◽  
Glycemic Control ◽  
Proliferative Diabetic Retinopathy ◽  
Study Groups ◽  
Hplc Method ◽  
P Value ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Cross Sectional ◽  
Institutional Review

Objectives: The aim of this study was to evaluate the major determinants of diabetic retinopathy. Study Design: Cross sectional, case control study. Setting: Department of Biochemistry, Basic Medical Sciences Institute, Jinnah Post Graduate Medical Centre, Karachi. Period: March 2015 to April 2016. Material & Methods: Ethical approval was taken from the Institutional Review Board of JPMC. A total of 208 people including type 2 diabetic patients and healthy control subjects; of male gender, aged between ≥30 years and ≤ 60 years were recruited and assigned to four study groups. Each group comprise of 52 individuals, depending on the ophthalmoscopy findings, i.e. healthy controls, diabetic without retinopathy (NDR), diabetic with non-proliferative diabetic retinopathy (NPDR) and diabetic with proliferative diabetic retinopathy (PDR). Fasting blood sugar was estimated using GOD-PAP method, while HbA1c was estimated by HPLC method. Data was analyzed on SPSS software version 16. Results: Diabetics with Diabetic Retinopathy had a poor glycemic control as compare to Diabetics without Diabetic Retinopathy (FBS; 109.12 ± 13.81 vs. 184.29 ± 40.07 vs. 188.6 ± 47.68 vs. 217.06 ± 62.33; p-value = 0.001) (HbA1c; 6.73 ± 0.56 vs. 8.40 ± 1.77 vs. 9.71 ± 1.85 vs. 14.91 ± 3.87; p-value = 0.001). For Diabetic Retinopathy the odds ratio of glycemic control i.e. FBS was observed as 1.019 & HbA1c was recorded as 1.561; which was statistically significant. Conclusion: Glycemic indicators; including FBS and HbA1c, are found to be the major determinants of Diabetic Retinopathy in our study.

Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients

Metabolism ◽  
2002 ◽  
Vol 51 (5) ◽  
pp. 544-548 ◽  
Author(s):  
Ataru Taniguchi ◽  
Yoshikatsu Nakai ◽  
Masahiko Sakai ◽  
Satoru Yoshii ◽  
Daizaburo Hamanaka ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Serum Triglyceride ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Regional Adiposity ◽  
Relationship Of ◽  
Type 2 Diabetic

Relationship of planter pressure and glycemic control in type 2 diabetic patients with and without neuropathy

2018 ◽  
Vol 12 (2) ◽  
pp. 99-104 ◽  
Author(s):  
Mohammed R. Halawa ◽  
Yara M. Eid ◽  
Rana A. El-Hilaly ◽  
Mona M. Abdelsalam ◽  
Amr H. Amer
Keyword(s):  
Glycemic Control ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Relationship Of ◽  
Type 2 Diabetic

scholarly journals TYPE 2 DIABETIC PATIENTS

2018 ◽  
Vol 25 (11) ◽  
pp. 1689-1695
Author(s):  
Mazhar Hussain ◽  
Muhammad Arshad Qureshi ◽  
Abdul Qudoos Arain ◽  
Habib-Ur- Rehman
Keyword(s):  
Vitamin D ◽  
Neuropathic Pain ◽  
Positive Impact ◽  
P Value ◽  
Diabetic Patients ◽  
Oral Vitamin ◽  
Type 2 Diabetic Patients ◽  
Peripheral Neuropathic Pain ◽  
Type 2 Diabetic

Background: Peripheral neuropathic pain is a devastating complication intype 2 diabetic patients with significant morbidity and mortality. Objectives: To investigate theeffect of oral vitamin D supplementation on symptoms of peripheral neuropathic pain in type 2diabetic patients. Study Design: Prospective randomized placebo controlled trial. Setting:Diabetic Clinic of Sheikh Zayed Medical College/Hospital Rahim Yar Khan. Period: Overa period of 6 months from Jan-July 2017. Methods: 116 vitamin D deficient type 2 diabeticpatients with symptoms of peripheral neuropathic pain were divided in to two groups toprescribed either oral vitamin D3 capsule 50000IU weekly or Placebo capsule for a periodof 12 weeks. Symptoms of diabetic neuropathic pain were assessed by neuropathysymptoms score (NSS) and neuropathy disability score (NDS) while Vitamin D status wasestimated by measuring the serum total 25(OH) D concentration. The primary end pointwas changes in NSS and NDS while secondary end point was changes in HbA1C and 25(OH) D concentrations from baseline. Results: After 12 weeks of vitamin D therapy, vitaminD improved its own level in interventional group (28.5±12.5 to 48.2±15.6) vs placebo group(30.6±16.2 to31.5±12.6) with p-value (0.001). This rise was accompanied by improvementin HbAIc (8.2±1.8 to 7.5±2.2) vs Placebo (7.8±1.5 to 8.0±1.8) with p-value (0.004) and NSSscore (6.02±1.5 to 4.52±0.8) vs placebo (5.82 ±1.8 to 5.65±1.5) with p-value (0.002). Howeverno significant changes were seen in NDS in both study groups. Conclusion: Oral vitamin D3therapy has positive impact on its own status as well as symptoms of peripheral neuropathicpain in type 2 diabetic patients.

scholarly journals Association of high density lipoprotein levels with advancing age in type 2 diabetes patients in Tertiary Hospital.

2019 ◽  
Vol 26 (09) ◽  
pp. 1471-1476
Author(s):  
Shahzad Alam Khan ◽  
Iqra Imtiaz
Keyword(s):  
Type 2 Diabetes ◽  
Density Lipoprotein ◽  
Hdl Cholesterol ◽  
P Value ◽  
Diabetic Patients ◽  
Adverse Cardiovascular Event ◽  
Type 2 Diabetic Patients ◽  
Cross Sectional ◽  
Low Hdl

Background: HDL particles have several biological functions. Low levels of HDL-cholesterol are responsible for atherosclerotic disease. Type 2 diabetes is a metabolic disease of chronic etiology and low HDL‐cholesterol is frequent finding in diabetics. Levels of HDL with advancing age are inconsistent, few study show decline in HDL with increasing age while others show vice versa results. Objectives: Objective of this study was to establish an association between low HDL levels with advancing age in type 2 diabetic patients. Study Design: Cross sectional descriptive study. Setting: Diabetes Outpatient Department Nishtar Hospital Multan. Period: 6 months extending from March 2018 to August 2018. Materials and Methods: 145 patients with newly or previously diagnosed type 2 diabetes mellitus, age >35 years were considered for the study. Those diabetics who had family history of dyslipidemias (to rule out familial hyperlipidemias) were excluded. Study was started after acquiring permission from ethical committee. All the patients were evaluated for the HDL levels by getting a fasting lipid assay. Results: Out of 145 cases 78 (53.6%) were males while remaining 67 (46.4%) were female. Mean age of the patients was 57.27 + 6.91 years. Mean HDL level was 37.82 + 8.42. It was seen that HDL is low in 116/145 (80%) patients. Those diabetic patients who were < 60 (91 cases), HDL was noticed to be low in 67/91(73.62%) patients. Among patients >60 years (54 cases), HDL was identified to be low in 49/54(90.7%) patients. P-value was found out to be 0.012 Conclusion: Due to falling levels of HDL with advancing age in diabetic patients, there is increase in cardiovascular events in elderly diabetic patients. So the measures which tend to increase HDL level will also give protection against adverse cardiovascular event in elderly diabetics.

scholarly journals Sitagliptin and Acute Pancreatitis: A Systematic Review and Meta-analysis

2021 ◽  
pp. 45-50
Author(s):  
Hyder Osman Mirghani ◽  
Salem Ahmed S. Shaman S. Shaman ◽  
Ibrahim Mahmoud Hussain Aljwah
Keyword(s):  
Systematic Review ◽  
Acute Pancreatitis ◽  
Meta Analysis ◽  
P Value ◽  
Significant Heterogeneity ◽  
Chi Square ◽  
Number Of Patients ◽  
The Usa ◽  
Peptidase Inhibitor ◽  
Relationship Of

Background and Objectives: Sitagliptin is a dipepidyl peptidase inhibitor (DPP-4i) with gentle antidiabetic effects with a lower risk of hypoglycemia. The association with acute pancreatitis is controversial. The current meta-analysis aimed to assess the relationship of sitagliptin and acute pancreatitis. Methods: The literature in PubMed and Google Scholar was searched for relevant articles published in the last ten years up to September 2021. The keywords sitagliptins, DPP-4i, acute pancreatitis were used with the protean AND or OR. Among the 204 articles retrieved, 24 full-texts were assessed for eligibility and only five studies (Three from the USA, one from Asia, and one from Canada) met the inclusion criteria for the systematic review. The author name, year of publication, country, type of study, number of patients, and the duration of the study were reported. Results: There were five studies. The total number of patients were 729808 with 6459 events. The studies showed no increased rate of acute pancreatitis following sitagliptin use, odd ratio, 0.79, 95% CI, 0.29-2.15, a significant heterogeneity was observer, I2 for heterogeneity=98%, P-value, <001, the P-value for overall effect was 0.65 and the chi-square, 160.15. Interpretation and Conclusion: Sitagliptin use is not associated with acute pancreatitis.

scholarly journals NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

2016 ◽  
Vol 23 (01) ◽  
pp. 029-033
Author(s):  
Nusrat Alavi ◽  
Saima Amin ◽  
Madiha Mumtaz
Keyword(s):  
Fatty Liver ◽  
Laboratory Data ◽  
Diabetic Group ◽  
Radiology Department ◽  
P Value ◽  
Diabetic Patients ◽  
Type Ii ◽  
Type 2 Diabetic Patients ◽  
Cross Sectional ◽  
Alcoholic Fatty Liver

Objectives: To assess the incidence of NAFLD and biochemical profile in nondiabeticand diabetic patients. Study Design: It was a cross sectional descriptive study. Setting:Shalamar Institute of Health Sciences (SIHS), Lahore. Period: Six months, Jan 2015 to Jun2015. Methods: The patients coming to the Radiology Department for abdominal ultrasoundwere age and sex matched into fatty liver and non-fatty liver groups and diabetic and nondiabeticgroups and were further evaluated on the basis of glucose, alanine aminotransferase(ALT) and triglycerides (TG) levels from the laboratory data. Results: The findings of allbiochemical parameters were raised in diabetic patients with fatty liver as well as in non-fattyliver diabetic group and the differences were found to be statistically (P value less than 0.05)significant. In non-diabetic group, out of 200 subjects 56.5% had NAFLD whereas 43.5% hadno NAFLD. In diabetic patients, out of 200 patients 69% had NAFLD and 31% had no NAFLDand the difference was significant statistically (P= <0.05). The prevalence of NAFLD 12.5%was higher in type-2 diabetic patients as compared to non-diabetic group. In non-diabeticgroup, 113 subjects had TG value of 181±82.49, while 87 subjects had TG of 141±44.5. Indiabetic patients, 138 patients had TG value of 467±277.64 whereas 62 patients had TG valueof 178±46.52, which was statistically significant (P= <0.05). Conclusion: Fatty liver is animportant marker for metabolic syndrome which is a pre-diabetic condition. The occurrenceof NAFLD was elevated in type II patients of diabetes. The traditional risk factors for NAFLDare considered to be female sex, type II diabetes mellitus, obesity and hypertriglyceridemia.Hyperglycemia, hypertriglyceridemia and elevated ALT were observed more repeatedly in fattyliver than in non-fatty liver (type II) diabetic patients

Sign in / Sign up

Export Citation Format

Share Document